Generic Arcoxia is used for treating acute and chronic pain, osteoarthritis and rheumatoid arthritis. It is also used for management of ankylosing spondylitis and relief of chronic musculoskeletal pain. It is also used for treating gout.
Generic Relafen is in a group of drugs called nonsteroidal anti-inflammatory drugs (NSAIDs). It works by reducing hormones that cause inflammation and pain in the body. It is used to treat pain or inflammation caused by arthritis.
Generic Naprosyn is used for treating rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, and juvenile arthritis. It is used to treat tendonitis, bursitis, gout, menstrual cramps, or mild to moderate pain.
Generic Celebrex is used for treating rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, juvenile arthritis or menstrual pain. It is also used in familial adenomatous polyposis (FAP) to decrease the number of polyps (growths) in the rectal area.
Online treatment reduces chronic knee pain from arthritis - Reuters
TheHealthSiteOnline treatment reduces chronic knee pain from arthritisReuters(Reuters Health) - A web-based program of exercise and coping skills training improves both function and pain in arthritic knees, a new study suggests.
The people with arthritis struggling to work - BBC News - BBC News
The people with arthritis struggling to work - BBC NewsBBC NewsSome 600,000 people with arthritis are missing out on the opportunity to work, according to the charity Arthritis Research UK.
Depression puts psoriasis patients at significantly greater risk of ... - Medical Xpress
Arthritis could be causing THIS common syndrome - causing ... - Express.co.uk
Efficacy of 23-Valent Pneumococcal Vaccine in Rheumatoid Arthritis Questioned - Infectious Disease Advisor (registration)
Efficacy of 23-Valent Pneumococcal Vaccine in Rheumatoid Arthritis QuestionedInfectious Disease Advisor (registration)The 23-valent pneumococcal polysaccharide vaccine (PPSV23) may not be effective for preventing pneumonia in patients with rheumatoid arthritis (RA) who are at risk for infections, according to a study published in Arthritis Research & Therapy.